Serum levels of the low-affinity interleukin-2 receptor molecule (TAC) during IL-2 therapy reflect systemic lymphoid mass activation
1989; Springer Science+Business Media; Volume: 29; Issue: 4 Linguagem: Inglês
10.1007/bf00199214
ISSN1432-0851
AutoresStephanD. Voss, JacquelynA. Hank, CatherineA. Nobis, Paul Fisch, JeffA. Sosman, PaulM. Sondel,
Tópico(s)Lymphoma Diagnosis and Treatment
Referência(s)